NGVT Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

266.93M

-10.66%

0.688

-27.63%

283.50M

-0.18%

0.903

-8.75%

375.63M

+2.89%

1.590

+14.39%

Estimates Revision

The market is revising Downward the revenue expectations for Ingevity Corporation (NGVT) for FY2025, with the revenue forecasts being adjusted by -6.03% over the past three months. During the same period, the stock price has changed by 18.26%.

Revenue Estimates for FY2025

Revise Downward

-6.03%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-9.02%

In Past 3 Month

Stock Price

Go Up

+18.26%

In Past 3 Month

2 Analyst Rating

Wall Street analysts forecast NGVT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NGVT is 62.00 USD with a low forecast of 55.00 USD and a high forecast of 69.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

1 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

55.00

Averages

62.00

High

69.00

Current: 0.000

Low

55.00

Averages

62.00

High

69.00

BMO Capital

Outperform

maintain

$64 -> $70

2025-12-10

Reason

BMO Capital

Price Target

$64 -> $70

2025-12-10

maintain

Outperform

Reason

BMO Capital raised the firm's price target on Ingevity to $70 from $64 and keeps an Outperform rating on the shares. Following its portfolio review, the company announced that it is looking to sell both the APT and road markings businesses while continuing to focus on growing the two core platforms in the activated carbon Performance Materials segment and the Paving Tech platform, the analyst tells investors in a research note. With the proceeds and significant free cash flow, the management will reduce debt as well as return 15% to shareholders in the form of buybacks over the next two years, the firm notes.

Wells Fargo

Michael Sison

Equal Weight

maintain

$52 -> $55

2025-11-12

Reason

Wells Fargo

Michael Sison

Price Target

$52 -> $55

2025-11-12

maintain

Equal Weight

Reason

Wells Fargo analyst Michael Sison raised the firm's price target on Ingevity to $55 from $52 and keeps an Equal Weight rating on the shares. The firm continues to await a more robust recovery in the global auto market, which remains uncertain.

BMO Capital

Outperform

maintain

$62 -> $68

2025-09-05

Reason

BMO Capital

Price Target

$62 -> $68

2025-09-05

maintain

Outperform

Reason

BMO Capital raised the firm's price target on Ingevity to $68 from $62 and keeps an Outperform rating on the shares. The company announced the sale of its CTO Refinery and most of the InSpec business in its Performance Chems platform for a solid high-teens multiple, and the firm sees this reducing earnings volatility and improving the margin profile of the business, the analyst tells investors in a research note.

BMO Capital

John McNulty

Outperform

maintain

$56 -> $62

2025-08-07

Reason

BMO Capital

John McNulty

Price Target

$56 -> $62

2025-08-07

maintain

Outperform

Reason

BMO Capital analyst John McNulty raised the firm's price target on Ingevity to $62 from $56 and keeps an Outperform rating on the shares after its Q2 earnings beat. Despite the solid 21% jump in the stock, the firm sees significant upside ahead for Ingevity as it has reached the inflection point in its earnings and free cash flow, the analyst tells investors in a research note.

Wells Fargo

Michael Sison

Hold

Maintains

$45 → $32

2025-04-09

Reason

Wells Fargo

Michael Sison

Price Target

$45 → $32

2025-04-09

Maintains

Hold

Reason

Wells Fargo lowered the firm's price target on Ingevity to $32 from $45 and keeps an Equal Weight rating on the shares. Given increased risks in a post tariff world, the firm recommends a more defensive position within the chemicals sector into Q1 2025 results as Wells expects cautious outlook commentary.

BMO Capital

John McNulty

Hold

Buy

Upgrades

$62 → $65

2025-02-26

Reason

BMO Capital

John McNulty

Price Target

$62 → $65

2025-02-26

Upgrades

Hold

Buy

Reason

BMO Capital analyst John McNulty raised the firm's price target on Ingevity to $62 from $61 and keeps a Market Perform rating on the shares after its Q4 earnings beat. The company is starting to reap the benefits of roughly two years of work to escape the pressures of its CTO - Crude Tall Oil - platform, the analyst tells investors in a research note. Ingevity is also seeing its high value add Performance Materials business enjoying growth despite muted end-market volumes, BMO adds.

Valuation Metrics

The current forward P/E ratio for Ingevity Corp (NGVT.N) is 12.58, compared to its 5-year average forward P/E of 13.07. For a more detailed relative valuation and DCF analysis to assess Ingevity Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

13.07

Current PE

12.58

Overvalued PE

16.37

Undervalued PE

9.78

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

8.55

Current EV/EBITDA

8.46

Overvalued EV/EBITDA

9.67

Undervalued EV/EBITDA

7.44

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

1.49

Current PS

1.68

Overvalued PS

1.95

Undervalued PS

1.03

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

NGVT News & Events

Events Timeline

No data

News

7.5

01-05Businesswire

Ingevity Completes $110 Million Sale of North Charleston CTO Refinery Assets

7.5

2025-11-11Newsfilter

CHASM and Ingevity Strengthen Partnership with Licensing Agreement to Ensure Local CNT Supply Chain for EV Battery Gigafactories in North America and Europe

5.0

2025-10-23Newsfilter

Ingevity appoints Ruth Castillo as senior vice president and head of Performance Materials

People Also Watch

Frequently Asked Questions

What is Ingevity Corp (NGVT) stock price today?

The current price of NGVT is 63.86 USD — it has increased 0.13 % in the last trading day.

What is Ingevity Corp (NGVT)'s business?

Ingevity Corporation develops, manufactures and brings to market solutions that help customers solve complex problems and make the world more sustainable. The Company operates in three reporting segments: Performance Materials, Advanced Polymer Technologies, and Performance Chemicals. The Performance Materials segment manufactures products in the form of powder, granular, extruded pellets, extruded honeycombs, and activated carbon sheets. Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. Performance Chemicals includes specialty chemicals and pavement technologies. The Company’s products are used in a variety of demanding applications, including adhesives, agrochemicals, asphalt paving, certified biodegradable bioplastics, coatings, elastomers, pavement markings and automotive components.

What is the price predicton of NGVT Stock?

What is Ingevity Corp (NGVT)'s revenue for the last quarter?

Ingevity Corp revenue for the last quarter amounts to 333.10M USD, decreased -0.21 % YoY.

What is Ingevity Corp (NGVT)'s earnings per share (EPS) for the last quarter?

Ingevity Corp. EPS for the last quarter amounts to 1.18 USD, decreased -140.00 % YoY.

What changes have occurred in the market's expectations for Ingevity Corp (NGVT)'s fundamentals?

How many employees does Ingevity Corp (NGVT). have?

Ingevity Corp (NGVT) has 1600 emplpoyees as of January 09 2026.

What is Ingevity Corp (NGVT) market cap?

Today NGVT has the market capitalization of 2.29B USD.